What is pemetinib and how much does a box cost?

Pemigatinib (Pemigatinib) is an innovative targeted therapy drug that plays an important role in the field of cancer treatment. As a kinase inhibitor, pemetinib can precisely act on specific molecular targets to inhibit the growth and spread of cancer cells. It mainly targets the key protein fibroblast growth factor receptor 2 (FGFR2). In cancer cells, abnormally activated FGFR2 will send division signals to cancer cells to promote their proliferation and spread. Pemetinib effectively inhibits the growth of cancer cells by blocking this signaling pathway, providing new treatment hope for cancer patients.

Pemetinib has shown significant efficacy in the treatment of cholangiocarcinoma. Cholangiocarcinoma is a malignant tumor originating from bile duct epithelial cells. Due to its special location and unclear early symptoms, it is often diagnosed at an advanced stage and is difficult to treat. However, pemetinib may be uniquely effective in patients with cholangiocarcinoma who have FGFR2 gene fusions or other changes in genomic structure. By specifically inhibiting the activity of FGFR2, it slows down the growth of cancer cells and may even shrink tumors.

In addition, pemetinib also has anti-angiogenic effects. It can inhibit the formation of new blood vessels inside the tumor, thus cutting off the tumor's supply of nutrients and oxygen, further weakening the tumor's vitality. This dual mechanism of action makes pemetinib more effective in cancer treatment.

As a targeted therapy drug, pemetinib has higher accuracy and lower toxicity than traditional chemotherapy drugs. It can act on cancer cells more accurately and reduce damage to normal cells, thereby reducing patients' side effects and pain. This makes pemetinib a new anti-cancer drug favored by doctors and patients.

Pemetinib is now available in the Chinese market, and patients can go directly to domestic hospitals to purchase it. The original version of pemetinib sold in China is available in 14 tablets of 4.5mg, with a market price of approximately 30,000 yuan. It is reported that both the original research version and the generic version are sold in foreign markets. The price of the original research version of 14 tablets of 13.5 mg is as high as 72,000 yuan, while the generic version produced by Lucius Pharmaceuticals in Laos only costs about 850 yuan with the same specifications. For more information about pemetinib, it is recommended to contact regular overseas medical service institutions.

xa0

Reference link: https://www.drugs.com/dosage/pemigatinib.html